Real-world sustained minimal residual disease (MRD) negativity using NGS in multiple myeloma.

被引：0
|
作者：
Demaree, Audrey [1 ]
Hewitt, Anthony [1 ]
Lee, Lik Wee [1 ]
Eckert, Benjamin [1 ]
机构：
[1] Adapt Biotechnol, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19280
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Alejandro Medina
    Noemi Puig
    Juan Flores-Montero
    Cristina Jimenez
    M.-Eugenia Sarasquete
    María Garcia-Alvarez
    Isabel Prieto-Conde
    Carmen Chillon
    Miguel Alcoceba
    Norma C. Gutierrez
    Albert Oriol
    Laura Rosinol
    Joan Bladè
    Mercedes Gironella
    Miguel T. Hernandez
    Veronica Gonzalez-Calle
    Maria-Teresa Cedena
    Bruno Paiva
    Jesus F. San-Miguel
    Juan-Jose Lahuerta
    Maria-Victoria Mateos
    Joaquin Martinez-Lopez
    Alberto Orfao
    Marcos Gonzalez
    Ramon Garcia-Sanz
    Blood Cancer Journal, 10
  • [42] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Medina, Alejandro
    Puig, Noemi
    Flores-Montero, Juan
    Jimenez, Cristina
    Sarasquete, M. -Eugenia
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gutierrez, Norma C.
    Oriol, Albert
    Rosinol, Laura
    Blade, Joan
    Gironella, Mercedes
    Hernandez, Miguel T.
    Gonzalez-Calle, Veronica
    Cedena, Maria-Teresa
    Paiva, Bruno
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Orfao, Alberto
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [43] Molecular monitoring of minimal residual disease after autologous or allogeneic transplantation for multiple myeloma.
    Corradini, P
    Tarella, C
    Astolfi, M
    Voena, C
    Ladetto, M
    Majolino, I
    Bacigalupo, A
    Boccadoro, M
    Pileri, A
    BLOOD, 1996, 88 (10) : 2464 - 2464
  • [44] Minimal Residual Disease in Multiple Myeloma
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
  • [45] Minimal residual disease for multiple myeloma
    Avet-Loiseau, Herve
    Corre, Jill
    HEMATOLOGIE, 2019, 25 : 36 - 39
  • [46] Minimal residual disease in multiple myeloma
    Moukalled, Nour
    Malard, Florent
    Bazarbachi, Ali
    Mohty, Mohamad
    PRESSE MEDICALE, 2025, 54 (01):
  • [47] MINIMAL RESIDUAL DISEASE DETECTION BY NEXT GENERATION FLOW-MRD IN MULTIPLE MYELOMA PATIENTS
    Sirianni, S.
    Gozzetti, A.
    Candi, V.
    Bocchia, M.
    Raspadori, D.
    HAEMATOLOGICA, 2016, 101 : S87 - S87
  • [48] Prognostic value of deep sequencing method for minimal residual disease (MRD) detection in multiple myeloma
    Martinez-Lopez, Joaquin
    Garcia-Sanz, Ramon
    Pepin, Francois
    Ayala, Rosa
    Angeles Montalban, Maria
    Paiva, Bruno
    Weng, Li
    Barrio, Santiago
    Montejano, Laura
    Rapado, Immaculada
    Martinez, Rafael
    Jesus Blachard, Maria
    Sanchez-Godoy, Pedro
    Blade, Joan
    San-Miguel, Jesus F.
    Faham, Malek
    Jose Lahuerta, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Predictors of unsustained measurable residual disease (MRD) negativity in transplant-eligible multiple myeloma (MM) patients
    Guerrero, Camila
    Puig, Noemi
    Cedena, Teresa
    Calasanz, Maria-Jose
    Gutierrez, Norma
    Fernandez-Guijarro, Manuela
    Oriol, Albert
    Rios, Rafael
    Hernandez Garcia, Miguel Teodoro
    Martinez-Martinez, Rafael
    Bargay, Joan
    de Arriba de la Fuente, Felipe
    Palomera, Luis
    Pilar Gonzalez-Rodriguez, Ana
    Gonzalez-Perez, Marta-Sonia
    Orfao, Alberto
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Blade, Joan
    Lahuerta Palacios, Juan Jose
    San-Miguel, Jesus
    Paiva, Bruno
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S7 - S8
  • [50] Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR
    Avet-Loiseau, Herve
    San-Miguel, Jesus
    Casneuf, Tineke
    Iida, Shinsuke
    Lonial, Sagar
    Usmani, Saad Z.
    Spencer, Andrew
    Moreau, Philippe
    Plesner, Torben
    Weisel, Katja
    Ukropec, Jon
    Chiu, Christopher
    Trivedi, Sonali
    Amin, Himal
    Krevvata, Maria
    Ramaswami, Priya
    Qin, Xiang
    Qi, Mia
    Sun, Steven
    Qi, Ming
    Kobos, Rachel
    Bahlis, Nizar J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (10) : 1139 - +
12345